Raia Drogasil S.A. (BVMF:RADL3)
Brazil · Delayed Price · Currency is BRL 23.58
-0.07 (-0.30%)
At close: Mar 13, 2026
Raia Drogasil Revenue
In the year 2025, Raia Drogasil had annual revenue of 44.25B BRL with 13.84% growth. Raia Drogasil had revenue of 12.10B in the quarter ending December 31, 2025, with 19.90% growth.
Revenue
44.25B
Revenue Growth
+13.84%
P/S Ratio
0.93
Revenue / Employee
598.83K
Employees
73,895
Market Cap
41.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.25B | 5.38B | 13.84% |
| Dec 31, 2024 | 38.87B | 4.90B | 14.42% |
| Dec 31, 2023 | 33.97B | 4.91B | 16.88% |
| Dec 31, 2022 | 29.07B | 4.94B | 20.48% |
| Dec 31, 2021 | 24.13B | 4.06B | 20.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 55.73B |
| Empreendimentos Pague Menos | 14.91B |
| Diagnósticos da América | 12.57B |
| Fleury | 8.29B |
| Hypera | 6.97B |
| Oncoclínicas do Brasil Serviços Médicos | 5.94B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |
| Odontoprev | 2.53B |
Raia Drogasil News
- 9 days ago - Raia Drogasil S.A. (RADLY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Raia Drogasil S.A. (RADLY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors - Seeking Alpha
- 11 months ago - Raia Drogasil: Valuation Burn Now, Healthy Gains Later - Seeking Alpha